SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-120193
Filing Date
2022-04-26
Accepted
2022-04-26 16:01:55
Documents
12
Period of Report
2022-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d264441d8k.htm   iXBRL 8-K 27399
  Complete submission text file 0001193125-22-120193.txt   146440

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dcph-20220426.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20220426_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20220426_pre.xml EX-101.PRE 10818
6 EXTRACTED XBRL INSTANCE DOCUMENT d264441d8k_htm.xml XML 3221
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 22854232
SIC: 2834 Pharmaceutical Preparations